Hepatitis C virus (HCV) infection is caused by an enveloped, single-stranded, linear ribonucleic acid (RNA) virus of the Flaviviridae family. Before 2011, pegylated interferon plus ribavirin (PR) was the gold standard of therapy to inhibit viral replication in patients with chronic hepatitis C (CHC). Approximately one-half of patients with genotype 1 CHC, the most prevalent type of CHC in Canada, could expect to achieve a sustained viral response (SVR) with PR therapy.
http://ift.tt/2ktlNTo
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τετάρτη 25 Ιανουαρίου 2017
Simeprevir (Galexos) (150 mg) [Internet].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου